Post on 12-Oct-2020
transcript
- 1 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 2 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
(1) Summary of the main conclusions:
Following 8 weeks of treatment twice daily (see table above): 47% of patients having an average of 55% improvement (above 40% each)
Following 16 weeks of treatment twice daily (see table above):
8.3% full clearance (100% improvement)
25% having an average of 89% improvement (above 83% each)
58% of patients having an average of 69% improvement (above 40% each)
- 3 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 4 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
(2) Reference studies:
http://www.advbiores.net/article.asp?issn=2277-
9175;year=2014;volume=3;issue=1;spage=11;epage=11;aulast=Iraji;aid=AdvBiomedRes_2014_3_1_11_124639
Efficacy of adding topical simvastatin to topical calcipotriol on improvement of cutaneous plaque psoriasis:
http://www.jhrr.org/article.asp?issn=2394-2010;year=2018;volume=5;issue=2;spage=86;epage=92;aulast=Goruntla
Study duration - 3 months
Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis:
- 5 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
(3) Clinical study protocol and report:
- 6 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 7 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 8 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 9 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 10 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 11 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 12 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 13 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 14 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 15 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 16 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 17 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 18 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 19 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 20 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
- 21 -
ClearSkin Ltd, Chen 28 St., Karmiel, Israel www.mibiome.co info@mibiome.co
PRELIMINARY CLINICAL STUDY RESULTS
Following 8 weeks of treatment twice daily (see table above):
47% of patients having an average of 55% improvement (above 40% each)
Following 16 weeks of treatment twice daily (see table above):
8.3% full clearance (100% improvement)
25% having an average of 89% improvement (above 83% each)
58% of patients having an average of 69% improvement (above 40% each)